
UnitedHealth Group seen as undervalued with strong long-term growth despite recent price gains and challenges.
UnitedHealth Group remains a strong long-term investment despite recent operational challenges and price increases. Management targets 13–16% bottom-line growth driven by margin recovery, AI investments, and share buybacks. Current valuations suggest...



